Epitope Discovery Program

NIAID supports research to enhance understanding of basic immunology, including immunity to infectious pathogens and the etiology, treatment, and prevention of immune-mediated diseases. Critical to this mission is the discovery and characterization of novel epitopes targeted by B and T lymphocyte cells.

New contracts awarded for Epitope Discovery

In September 2024, NIAID awarded six contracts under the Innovations in Functional B Cell Immune Epitope Discovery Program and five contracts under the T Cell Immune Epitope Discovery and Mechanisms of T Cell Protection Program.

The Epitope Discovery Program is comprised of two complementary programs: 1) Innovations in Functional B Cell Epitope Discovery, and 2) T Cell Immune Epitope Discovery and Mechanisms of T Cell Protection. Together, these programs support the following areas of research:

  • Discovery of novel epitopes associated with human responses to pathogens that cause chronic or acute infection, including pathogens with pandemic potential
  • Discovery of novel epitopes associated with human allergic responses, development of autoimmune disease, and transplant rejection
  • Structural characterization of epitopes: monoclonal antibody binding and MHC-peptide: TCR binding
  • Validation of the functional role of epitopes in human disease (i.e., participation in immune protection or pathogenesis)
  • Deposition of epitope data into the Immune Epitope Database and Analysis Resource (IEDB)

Additionally, NIAID funds two supporting resources that are available to the biomedical community: the Immune Epitope Database and Analysis Resource (IEDB) and the Tetramer Core Facility.

Resources

NIH Tetramer Core Facility (TCF)

Reagents to detect and quantify antigen-specific T cells.


Read more about TCF

Immune Epitope Database and Analysis Resource (IEDB)

Catalog of B cell- and T cell-specific epitopes and MHC ligands for infectious and immune-mediated diseases (allergy, autoimmunity, transplant rejection).


Read more about IEDB

Contact Information

Email Epitope Discovery for questions or help.

Content last reviewed on